173 related articles for article (PubMed ID: 26679445)
1. Examining Differences in Opportunity and Eligibility for Cancer Clinical Trial Participation Based on Sociodemographic and Disease Characteristics.
Rearden J; Hanlon AL; Ulrich C; Brooks-Carthon M; Sommers M
Oncol Nurs Forum; 2016 Jan; 43(1):57-66. PubMed ID: 26679445
[TBL] [Abstract][Full Text] [Related]
2. Barriers to therapeutic clinical trials enrollment: differences between African-American and white cancer patients identified at the time of eligibility assessment.
Penberthy L; Brown R; Wilson-Genderson M; Dahman B; Ginder G; Siminoff LA
Clin Trials; 2012 Dec; 9(6):788-97. PubMed ID: 23033547
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic Cancer Clinical Treatment Trials Accrual: A Closer Look at Participation Rates.
Guerra CE; Kelly S; Redlinger C; Hernández P; Glanz K
Am J Clin Oncol; 2021 Jun; 44(6):227-231. PubMed ID: 33710138
[TBL] [Abstract][Full Text] [Related]
4. Disparities in clinical trial participation in ovarian cancer: A real-world analysis.
Smith AJB; Alvarez R; Heintz J; Simpkins F; Ko EM
Gynecol Oncol; 2023 Aug; 175():25-31. PubMed ID: 37300995
[TBL] [Abstract][Full Text] [Related]
5. Barriers to minority participation in breast carcinoma prevention trials.
Grann VR; Jacobson JS; Troxel AB; Hershman D; Karp J; Myers C; Neugut AI
Cancer; 2005 Jul; 104(2):374-9. PubMed ID: 15937913
[TBL] [Abstract][Full Text] [Related]
6. The impact of socioeconomic status and race on trial participation for older women with breast cancer.
Gross CP; Filardo G; Mayne ST; Krumholz HM
Cancer; 2005 Feb; 103(3):483-91. PubMed ID: 15597407
[TBL] [Abstract][Full Text] [Related]
7. Association of Remote Technology Use and Other Decentralization Tools With Patient Likelihood to Enroll in Cancer Clinical Trials.
Adams DV; Long S; Fleury ME
JAMA Netw Open; 2022 Jul; 5(7):e2220053. PubMed ID: 35788672
[TBL] [Abstract][Full Text] [Related]
8. Recruitment and participation in clinical trials: socio-demographic, rural/urban, and health care access predictors.
Baquet CR; Commiskey P; Daniel Mullins C; Mishra SI
Cancer Detect Prev; 2006; 30(1):24-33. PubMed ID: 16495020
[TBL] [Abstract][Full Text] [Related]
9. Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program.
Langford AT; Resnicow K; Dimond EP; Denicoff AM; Germain DS; McCaskill-Stevens W; Enos RA; Carrigan A; Wilkinson K; Go RS
Cancer; 2014 Mar; 120(6):877-84. PubMed ID: 24327389
[TBL] [Abstract][Full Text] [Related]
10. Knowledge and attitudes regarding clinical trials and willingness to participate among prostate cancer patients.
Kaplan CP; Nápoles AM; Narine S; Gregorich S; Livaudais-Toman J; Nguyen T; Leykin Y; Roach M; Small EJ
Contemp Clin Trials; 2015 Nov; 45(Pt B):443-448. PubMed ID: 26435199
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Factors Associated With Parental Perceptions of Voluntary Decisions About Child Participation in Leukemia Clinical Trials.
Aristizabal P; Ma AK; Kumar NV; Perdomo BP; Thornburg CD; Martinez ME; Nodora J
JAMA Netw Open; 2021 May; 4(5):e219038. PubMed ID: 33944924
[TBL] [Abstract][Full Text] [Related]
12. Participation in cancer clinical trials: race-, sex-, and age-based disparities.
Murthy VH; Krumholz HM; Gross CP
JAMA; 2004 Jun; 291(22):2720-6. PubMed ID: 15187053
[TBL] [Abstract][Full Text] [Related]
13. Evaluating a community-partnered cancer clinical trials pilot intervention with African American communities.
Green MA; Michaels M; Blakeney N; Odulana AA; Isler MR; Richmond A; Long DG; Robinson WS; Taylor YJ; Corbie-Smith G
J Cancer Educ; 2015 Mar; 30(1):158-66. PubMed ID: 25564207
[TBL] [Abstract][Full Text] [Related]
14. Health Insurance Payer Type and Ethnicity Are Associated with Cancer Clinical Trial Enrollment Among Adolescents and Young Adults.
Sullenger RD; Deal AM; Grilley Olson JE; Matson M; Swift C; Lux L; Smitherman AB
J Adolesc Young Adult Oncol; 2022 Feb; 11(1):104-110. PubMed ID: 34010032
[No Abstract] [Full Text] [Related]
15. A prospective comparison of cancer clinical trial availability and enrollment among adolescents/young adults treated at an adult cancer hospital or affiliated children's hospital.
Thomas SM; Malvar J; Tran HH; Shows JT; Freyer DR
Cancer; 2018 Oct; 124(20):4064-4071. PubMed ID: 30291804
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center.
Simon MS; Du W; Flaherty L; Philip PA; Lorusso P; Miree C; Smith D; Brown DR
J Clin Oncol; 2004 Jun; 22(11):2046-52. PubMed ID: 15082724
[TBL] [Abstract][Full Text] [Related]
17. Discussions about clinical trials among patients with newly diagnosed lung and colorectal cancer.
Kehl KL; Arora NK; Schrag D; Ayanian JZ; Clauser SB; Klabunde CN; Kahn KL; Fletcher RH; Keating NL
J Natl Cancer Inst; 2014 Oct; 106(10):. PubMed ID: 25217775
[TBL] [Abstract][Full Text] [Related]
18. The role of race and ethnicity in the State Children's Health Insurance Program (SCHIP) in four states: are there baseline disparities, and what do they mean for SCHIP?
Shone LP; Dick AW; Brach C; Kimminau KS; LaClair BJ; Shenkman EA; Col JF; Schaffer VA; Mulvihill F; Szilagyi PG; Klein JD; VanLandeghem K; Bronstein J
Pediatrics; 2003 Dec; 112(6 Pt 2):e521. PubMed ID: 14654674
[TBL] [Abstract][Full Text] [Related]
19. Experiences of Patients After Withdrawal From Cancer Clinical Trials.
Ulrich CM; Knafl K; Foxwell AM; Zhou Q; Paidipati C; Tiller D; Ratcliffe SJ; Wallen GR; Richmond TS; Naylor M; Gordon TF; Grady C; Miller V
JAMA Netw Open; 2021 Aug; 4(8):e2120052. PubMed ID: 34374772
[TBL] [Abstract][Full Text] [Related]
20. Challenging assumptions about minority participation in US clinical research.
Fisher JA; Kalbaugh CA
Am J Public Health; 2011 Dec; 101(12):2217-22. PubMed ID: 22021285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
